Sandoz Group AG | Finanzwire

Basculer en Français

10837	Companies
235317	Keywords
164235	Articles
126046	Press releases

Home
Companies
Sandoz Group AG

BRIEF

published on 08/17/2026 at 02:05, 6 hours ago

Sandoz and Henlius Forge Major Biosimilar Collaboration

Market Expansion Sandoz Biosimilar Collaboration Henlius Pharmaceutical Pipeline
PRESS RELEASE

published on 08/17/2026 at 02:00, 6 hours 5 minutes ago

Sandoz announces strategic collaboration with Henlius on up to 10 biosimilars, further expanding industry-leading pipeline
Sandoz announces strategic collaboration with Henlius on up to 10 biosimilars, expanding industry-leading pipeline. Agreement includes cetuximab, evolocumab, belimumab biosimilars, and option for human hyaluronidase

Collaboration Biosimilars Pipeline Sandoz Henlius
BRIEF

published on 08/05/2026 at 07:05, 12 days 1 hour ago

Sandoz Reports Strong H1 2026 Financial Results

Net Sales Increase Sandoz Group AG Biosimilars Growth H1 2026 Financial Results Core EBITDA Improvement
PRESS RELEASE

published on 08/05/2026 at 07:00, 12 days 1 hour ago

Sandoz delivers strong H1 2026 results, with outstanding biosimilar growth in the second quarter
Sandoz delivers strong H1 2026 results, with outstanding biosimilar growth in the second quarter. Company confirms full-year guidance amidst solid financial performance

Financial Performance Guidance Sandoz H1 2026 Results Biosimilar Growth
BRIEF

published on 08/03/2026 at 07:05, 14 days 1 hour ago

Sandoz Advances in Resolving US Generic Medicine Litigation

Pharmaceutical Market Legal Resolution Sandoz Settlements US Generic Litigation Antitrust Claims
PRESS RELEASE

published on 08/03/2026 at 07:00, 14 days 1 hour ago

Sandoz takes further steps to resolve legacy US generic medicine litigation
Sandoz Group AG announces settlements to resolve US generic medicine litigation with 43 states & territories and indirect resellers, with no impact on financial outlook

Litigation Settlements Financial Outlook Sandoz US Generic Medicine
BRIEF

published on 07/29/2026 at 11:35, 18 days 20 hours ago

Sandoz Gains Approval for Semaglutide Treatment in Brazil

Brazil Regulatory Approval Diabetes Treatment Sandoz Semaglutide
PRESS RELEASE

published on 07/29/2026 at 11:30, 18 days 20 hours ago

Sandoz confirms regulatory approval for new semaglutide treatment option in Brazil, paving way to expand patient access
Sandoz receives regulatory approval for Owozy®, a new semaglutide treatment for type-2 diabetes in Brazil, enhancing patient access and supporting local healthcare systems

Brazil Regulatory Approval Sandoz Semaglutide Patient Access
BRIEF

published on 07/15/2026 at 07:05, 1 month 2 days ago

Sandoz Announces Key Leadership Changes

Leadership Changes Healthcare Access Sandoz Strategy Global M&A Generics Manufacturing
PRESS RELEASE

published on 07/15/2026 at 07:00, 1 month 2 days ago

Sandoz announces key leadership changes
Sandoz announces key leadership changes: Pascal Bouye appointed President, Generics Manufacturing & Supply; Glenn Gerecke takes on new role within the company. Keren Haruvi to oversee global M&A activities. Simon Goeller appointed Country President, Germany

Leadership Changes Sandoz Pascal Bouye Keren Haruvi Simon Goeller

1 2 ... 7

Accesswire

Published on 08/15/2026 at 00:50, 2 days 7 hours ago

Revive Therapeutics Reports Grant of Options
Published on 08/15/2026 at 00:15, 2 days 7 hours ago

Full Circle Lithium Announces Closing of Private Placement
Published on 08/14/2026 at 23:45, 2 days 8 hours ago

AI/ML Innovations Inc. Announces Proposed Private Placement
Published on 08/14/2026 at 23:25, 2 days 8 hours ago

NuRAN Wireless Closes $7.6 Million Financing
Published on 08/14/2026 at 23:00, 2 days 9 hours ago

Medicure Reports Financial Results for Quarter Ended June 30, 2026 and Schedules August 17, 2026 Conference Call

View all ACCESSWIRE

EQS Group

Published on 08/17/2026 at 07:45, 20 minutes ago

Mayr-Melnhof Karton AG: MM Board & Paper signs agreement to acquire the operations of R.D.M. Arnsberg
Published on 08/17/2026 at 07:32, 32 minutes ago

Mister Spex expands its core business into children’s eyewear
Published on 08/17/2026 at 07:00, 1 hour 5 minutes ago

SIG Group AG: Ann-Kristin Erkens appointed new CEO of SIG
Published on 08/17/2026 at 06:00, 2 hours 5 minutes ago

HIAG reports significant increase in net income for the first half of 2026
Published on 08/17/2026 at 02:00, 6 hours 5 minutes ago

Sandoz announces strategic collaboration with Henlius on up to 10 biosimilars, further expanding industry-leading pipeline

Les Echos

Published on 08/17/2026 at 07:30, 35 minutes ago

Disclosure of transactions in own shares from August 10 to August 14, 2026
Published on 08/10/2026 at 18:00, 6 days 14 hours ago

AXA: Information relating to the number of voting rights and shares making up the share capital on 31/07/2026
Published on 08/10/2026 at 17:45, 6 days 14 hours ago

Weekly share buyback
Published on 08/10/2026 at 11:53, 6 days 20 hours ago

GUILLEMOT CORPORATION | Information regarding the total number of voting rights and shares 31/07/2026
Published on 08/10/2026 at 11:36, 6 days 20 hours ago

GUILLEMOT CORPORATION| Weekly report share buyback from August 3 to August 7 2026

View all LES ECHOS COMFI WIRE